TJPC: Compound Amino Acids (15) Dipeptide (2) Injection has obtained a drug registration certificate
I'm PortAI, I can summarize articles.
TJPC announced that its subsidiary TJPC HePing has obtained the drug registration certificate for Compound Amino Acid (15) Dipeptide (2) Injection issued by the National Medical Products Administration. This drug is used for parenteral nutrition therapy and is suitable for patients who cannot receive nutrition orally or through the gastrointestinal tract, especially those with moderate to severe catabolic states
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments